Skip to main content
Clinical Trials/NCT04271124
NCT04271124
Unknown
Not Applicable

Comparison of Exercise Training

Faculty of Medicine, Sousse1 site in 1 country40 target enrollmentMay 2020
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Faculty of Medicine, Sousse
Enrollment
40
Locations
1
Primary Endpoint
Change of Interleukins concentrations
Last Updated
6 years ago

Overview

Brief Summary

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020.

Detailed Description

COPD is a common, preventable treatable disease that is characterized by an airflow limitation which is not fully reversible.Not only the long-term exposition to noxious particles and gases contributes to the development of COPD, but also many others factors such as genetics and cigarette smoking. Cigarettes are harmful and contribute to different extra pulmonary disorders. Although COPD affects lungs some extrapulmonary manifestations are prescribed such as muscle dysfunction, abnormal respiratory muscles and systemic inflammation. Indeed, the systemic inflammation\[6, 8\] is considered as a key process in the pathogenesis of COPD. It involves different cells and molecules; high levels of circulating of white blood cells, increased plasma c-reactive proteins (CRP), interleukin 6 (Il6) have been reported in.those patients.Likewise, systemic inflammation could worsen the comorbidities (cardiovascular, osteoporosis..) and may lead to the exercise limitation.

Registry
clinicaltrials.gov
Start Date
May 2020
End Date
July 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Faculty of Medicine, Sousse
Responsible Party
Principal Investigator
Principal Investigator

Acheche Amal

PhD

Faculty of Medicine, Sousse

Eligibility Criteria

Inclusion Criteria

  • COPD diagnosed by pulmonary function testing
  • Clinically stable
  • Abscence of other obstructive diseases
  • Signed written consent

Exclusion Criteria

  • Neuromuscular diseases -Severe psychiatric, neurologic or musculoskeletal conditions
  • cardiovascular diseases.
  • Contre-indications to physical therapy
  • Acute exacerbations a month before the intervention

Outcomes

Primary Outcomes

Change of Interleukins concentrations

Time Frame: Before the training, 2 months

ELISA assay

Secondary Outcomes

  • 6Minutes Walk test(Before the training, 2 months)

Study Sites (1)

Loading locations...

Similar Trials